Advanced in Pulmonary Hypertension

Dr. Robert Bourge

Cardiology
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham,, AL 
Advanced in Pulmonary Hypertension
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham,, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Bourge is a Cardiologist in Birmingham,, Alabama. Dr. Bourge is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Heart Failure, Hypertension, Pulmonary Hypertension, Stent Placement, and Heart Transplant.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles and participated in 4 clinical trials in the study of Pulmonary Hypertension.

Specialties
Cardiology
Licenses
Internal Medicine in AL
Hospital Affiliations
University Of Alabama Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

University of Alabama Health Services Foundation PC
2000 6th Ave S, Birmingham,, AL 35233
Call: 205-801-8000
Other Locations
Office
1900 University Blvd, Birmingham,, AL 35233
Call: 205-934-3438

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

48 Total Publications

Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring.
Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring.
Journal: Journal of cardiac failure
Published: May 12, 2022
View All 48 Publications
Similar Doctors
Jose A. Tallaj
Distinguished in Pulmonary Hypertension
Dr. Jose A. Tallaj
Advanced Heart Failure and Transplant Cardiology | Cardiology
Distinguished in Pulmonary Hypertension
Dr. Jose A. Tallaj
Advanced Heart Failure and Transplant Cardiology | Cardiology

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
 (0.1 miles away)
205-934-4011
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jose Tallaj is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Birmingham, Alabama. Dr. Tallaj is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Heart Failure, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Transplant, and Endoscopy. Dr. Tallaj is currently accepting new patients.

Distinguished in Pulmonary Hypertension
Dr. Andrew J. Lenneman
Cardiology | Advanced Heart Failure and Transplant Cardiology
Distinguished in Pulmonary Hypertension
Dr. Andrew J. Lenneman
Cardiology | Advanced Heart Failure and Transplant Cardiology

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
 (0.1 miles away)
205-934-4011
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Lenneman is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Birmingham, Alabama. Dr. Lenneman is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Heart Failure, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Transplant, and Cardiac Ablation. Dr. Lenneman is currently accepting new patients.

Advanced in Pulmonary Hypertension
Dr. Ayman Haj Asaad
Advanced Heart Failure and Transplant Cardiology | Cardiology
Advanced in Pulmonary Hypertension
Dr. Ayman Haj Asaad
Advanced Heart Failure and Transplant Cardiology | Cardiology

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
 (0.1 miles away)
205-934-4011
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ayman Haj Asaad is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Birmingham, Alabama. Dr. Haj Asaad is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, Pulmonary Edema, and Cardiac Ablation. Dr. Haj Asaad is currently accepting new patients.

VIEW MORE PULMONARY HYPERTENSION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bourge's expertise for a condition
ConditionClose
      • Advanced
      • Heart Failure
        Dr. Bourge is
        Advanced
        . Learn about Heart Failure.
        See more Heart Failure experts
      • Hypertension
        Dr. Bourge is
        Advanced
        . Learn about Hypertension.
        See more Hypertension experts
      • Pulmonary Hypertension
        Dr. Bourge is
        Advanced
        . Learn about Pulmonary Hypertension.
        See more Pulmonary Hypertension experts
      • Experienced
      • Cardiomyopathy
        Dr. Bourge is
        Experienced
        . Learn about Cardiomyopathy.
        See more Cardiomyopathy experts
      • Cardiomyopathy Due to Anthracyclines
        Dr. Bourge is
        Experienced
        . Learn about Cardiomyopathy Due to Anthracyclines.
        See more Cardiomyopathy Due to Anthracyclines experts
      • Doxorubicin-Induced Cardiomyopathy
        Dr. Bourge is
        Experienced
        . Learn about Doxorubicin-Induced Cardiomyopathy.
        See more Doxorubicin-Induced Cardiomyopathy experts
      • Familial Hypertrophic Cardiomyopathy
        Dr. Bourge is
        Experienced
        . Learn about Familial Hypertrophic Cardiomyopathy.
        See more Familial Hypertrophic Cardiomyopathy experts
      • Heart Failure with Preserved Ejection Fraction (HFpEF)
        Dr. Bourge is
        Experienced
        . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
        See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
      • Heart Transplant
        Dr. Bourge is
        Experienced
        . Learn about Heart Transplant.
        See more Heart Transplant experts
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.